Precision Telemed Review

Our assessment

Precision Telemed publishes flat monthly rates that don't move as the dose climbs, and says which dose range each plan covers. Both priced pages state that no membership fee and no subscription apply, and individual clinicians are named with a federal provider number. It also prints a sentence about its own pharmacies that the FDA has publicly called false or misleading, which is a good reason to read everything else on the page literally.

A flat rate, and it tells you which doses it's flat across

On a dose-tiered plan the bill rises at exactly the point the medication starts working. Precision Telemed doesn't do that. It publishes one figure per drug that holds every month, and prints the dose range that figure covers next to it.

That second half is the unusual part. Plenty of sellers advertise a flat rate. Far fewer tell you which doses it's flat across. The semaglutide program names its range and the tirzepatide program names its own, so you can tell before buying whether the dose you expect to reach is inside the price.

The tirzepatide program opens on a lower first month and states the ongoing rate in the same sentence. The ongoing rate is the one that describes a year.

The maintenance plans are a different product, not a discount

Each drug also has a maintenance lane priced below the full program, and each is restricted to the lowest dose. The seller says so in plain words on both pages.

That restriction is doing all the work. A maintenance plan is for someone who has already reached their weight and is holding it, not for someone starting treatment and titrating upward.

Sort a price comparison and the maintenance figure is the first thing you'll see. It is not the figure that describes your first year.

The sentence the FDA has publicly called false

A disclaimer on both product pages says the medications are made in state-board-licensed sterile compounding pharmacies, or in FDA-licensed outsourcing facilities. That last phrase describes nothing. The agency doesn't approve or license any facility, and its own guidance to telehealth companies names that exact claim as false or misleading.

That isn't an accusation about the medicine and it isn't an enforcement action. It is a sentence about regulatory status that isn't true as written, on a page whose whole purpose is to establish trust about regulatory status.

Take something narrow and useful from it. Read this company's regulatory language literally rather than generously, and don't treat a mention of the agency on a compounded product page as approval of anything. The company has no warning letter in the agency's published record.

No membership, stated twice, on the right pages

The semaglutide page says no membership fee. The tirzepatide page says no subscription required and everything included, no hidden fees. One hundred and twenty-nine of the four hundred and twenty sellers here state something equivalent.

Where it's stated matters here more than usual, because the same site sells several unrelated wellness products. A fee promise about a storefront isn't a fee promise about a GLP-1 plan. These two sit on the GLP-1 product pages themselves.

So the plan figure is closer to your actual bill than a headline from a seller who charges a separate monthly membership underneath the medication price.

What's named and what's only described

Precision Telemed names individual clinicians with credentials and a federal provider number you can check in a national registry. Five sellers here publish a prescriber's number that way, and this is one of them. Those numbers are the seller's own published claims.

It also says plainly on every page that the platform and the medical practice are two entities, and names both. Most of this field leaves that implicit.

The pharmacy is described by licensing class and never named. A licensing category tells you what kind of pharmacy is involved. It doesn't let you look up the one preparing your medication, and on a site whose regulatory wording already needs care, a name would have been worth a lot.